Mar 3, 2026 08:03AM
Mar 3, 2026 08:01AM
Feb 25, 2026 07:19AM
Feb 25, 2026 07:18AM
Feb 23, 2026 06:36AM
Feb 23, 2026 05:19AM
Feb 20, 2026 05:59PM Vanda gets FDA approval for psychiatric drug BYSANTI
Feb 20, 2026 05:59PM
Feb 11, 2026 04:01PM
Jan 8, 2026 07:01AM
Jan 8, 2026 07:00AM
Jan 5, 2026 06:41AM
Dec 31, 2025 04:25AM
Dec 30, 2025 06:13PM FDA approves Vanda's NEREUS for motion sickness prevention
Dec 30, 2025 06:13PM
Dec 17, 2025 07:30AM
Dec 15, 2025 07:01AM
Dec 15, 2025 07:00AM
Dec 4, 2025 04:22PM
Dec 4, 2025 04:21PM
Dec 1, 2025 06:35AM H.C. Wainwright Reiterates Buy Rating on Vanda Pharmaceuticals (VNDA)
Nov 28, 2025 07:00AM
Nov 28, 2025 07:00AM
Nov 17, 2025 06:37PM
Oct 29, 2025 04:01PM
Oct 2, 2025 06:45AM
Oct 1, 2025 05:03PM
Oct 1, 2025 05:02PM Vanda Pharmaceuticals Announces Collaborative Framework for Resolution of Disputes with the U.S. Food and Drug Administration
Sep 25, 2025 08:03AM
Sep 25, 2025 08:00AM
Aug 28, 2025 07:00AM
Aug 28, 2025 07:00AM
Aug 21, 2025 04:40PM
Aug 21, 2025 04:40PM
Aug 21, 2025 06:36AM H.C. Wainwright Reiterates Buy Rating on Vanda Pharmaceuticals (VNDA)
Aug 18, 2025 07:01AM
Aug 18, 2025 07:00AM
Jul 31, 2025 07:30AM
May 14, 2025 09:03AM
May 7, 2025 04:01PM
May 5, 2025 08:00AM
May 5, 2025 08:00AM Vanda Announces Bysanti™ NDA Filing; FDA Decision Expected in Early 2026
Apr 23, 2025 03:57PM
Apr 23, 2025 03:52PM
Apr 7, 2025 08:00AM
Mar 31, 2025 08:00AM
Mar 31, 2025 08:00AM
Mar 19, 2025 06:44AM
Feb 24, 2025 07:06AM Vanda Pharmaceuticals (VNDA) announces the publication of an article titled "Potential ASO-based personalized treatment for Charcot-Marie-Tooth disease type 2S"
Feb 24, 2025 07:00AM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All